Similar articles

• Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin.

  Koller M, Schoch U, Buchmann P, Largiadèr F, von Felten A, Frick PG. Koller M, et al. Thromb Haemost. 1986 Dec 15;56(3):243-6. Thromb Haemost. 1986. PMID: 3551180 Clinical Trial.
• [Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery].

  Grunebaum L, Fricker JP, Wiesel ML, Vergnes Y, Kapps J, Cazenave JP. Grunebaum L, et al. J Mal Vasc. 1987;12 Suppl B:102-4. J Mal Vasc. 1987. PMID: 2834478 Clinical Trial. French.
• On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failure.

  Lane DA, Flynn A, Ireland H, Anastassiades E, Curtis JR. Lane DA, et al. Haemostasis. 1986;16 Suppl 2:38-47. doi: 10.1159/000215356. Haemostasis. 1986. PMID: 3744134
• The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options.

  Agnelli G, Caprini JA. Agnelli G, et al. J Surg Oncol. 2007 Sep 1;96(3):265-72. doi: 10.1002/jso.20808. J Surg Oncol. 2007. PMID: 17474075 Review.
• Clinical use of heparin fractions, fragments, and heparinoids.

  Messmore HL Jr. Messmore HL Jr. Semin Thromb Hemost. 1985 Apr;11(2):208-12. doi: 10.1055/s-2007-1004376. Semin Thromb Hemost. 1985. PMID: 2412297 Review. No abstract available.